ginsenoside rh2 has been researched along with parthenolide in 1 studies
| Studies (ginsenoside rh2) | Trials (ginsenoside rh2) | Recent Studies (post-2010) (ginsenoside rh2) | Studies (parthenolide) | Trials (parthenolide) | Recent Studies (post-2010) (parthenolide) |
|---|---|---|---|---|---|
| 295 | 1 | 200 | 612 | 5 | 323 |
| Protein | Taxonomy | ginsenoside rh2 (IC50) | parthenolide (IC50) |
|---|---|---|---|
| Nitric oxide synthase, inducible | Mus musculus (house mouse) | 4.525 | |
| Prostaglandin G/H synthase 2 | Homo sapiens (human) | 0.8 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cai, N; Jin, X; Yang, Q; Zhang, Z | 1 |
1 other study(ies) available for ginsenoside rh2 and parthenolide
| Article | Year |
|---|---|
A cocktail of betulinic acid, parthenolide, honokiol and ginsenoside Rh2 in liposome systems for lung cancer treatment.
Topics: A549 Cells; Animals; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Betulinic Acid; Biphenyl Compounds; Cell Proliferation; Cisplatin; Ginsenosides; Humans; Lignans; Liposomes; Lung Neoplasms; Mice; Neoplasm Invasiveness; Pentacyclic Triterpenes; Sesquiterpenes; Triterpenes; Xenograft Model Antitumor Assays | 2020 |